Breakthrough stem cell therapy reverses Parkinson’s in Chinese patient

Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...
Le Lézard

New clinical data highlights CAPLYTA® (lumateperone) as a promising option for achieving remission in adults with major depressive disorder

Johnson & Johnson today announced a new analysis of Phase 3 data which found CAPLYTA® (lumateperone), in combination with an ...
RMD Open

Spotlight on Sjögren’s: a patient perspective on burden of illness and unmet needs – results from a real-world survey

Objective Sjögren’s is a chronic systemic autoimmune disease characterised by dryness symptoms (eyes, mouth, skin), alongside ...